Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia-Reference-Cited by-全球学者库

Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia

Published:2018-05 Issue: Volume:263 Page:147-153
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Xiu Mei-Hong,Wang Dong,Chen Song,Du Xiang-Dong,Chen Da-Chun,Chen Nan,Wang Yue-Chan,Yin Guangzhong,Zhang Yingyang,Tan Yun-Long,Cho Raymond Y.,Soares Jair C.,Zhang Xiang-Yang

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference72 articles.

1. Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways;Anderson;Prog. Neuropsychopharmacol. Biol. Psychiatry,2013

2. Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia;Asevedo;Physiol. Behav.,2014

3. Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring;Bauman;Biol. Psychiatry,2014

4. Microglial control of neuronal death and synaptic properties;Bessis;Glia,2007

5. Associations between maternal infection during pregnancy, childhood infections, and the risk of subsequent psychotic disorder – a Swedish cohort study of nearly 2 million individuals;Blomstrom;Schizophr. Bull.,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum total cholesterol levels associated with immediate memory performance in patients with chronic schizophrenia;Schizophrenia Research;2023-05

2. Neurocognitive Deficits in First-Episode and Chronic Psychotic Disorders: A Systematic Review from 2009 to 2022;Brain Sciences;2023-02-10

3. Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease;Journal of Neuroinflammation;2022-12-29

4. Lysophosphatidylethanolamine correlated with cognitive improvements after treatment with olanzapine in drug-naïve first-episode schizophrenia: a prospective cohort study;2022-12-21

5. Association between MnSOD Activity and Cognitive Impairment in Unmedicated First-Episode Schizophrenia: Regulated by MnSOD Ala-9Val Gene Polymorphism;Antioxidants;2022-10-04